EYLEA is the #1
prescribed anti-VEGF
FDA approved for Wet
AMD, DME,
and MEfRVO*
*IBM Truven MarketScan data:
Number of injections
administered from Q4 2017
through Q3 2018; data on file.

The flexibility of a broad range of indications and dosing flexibility across several FDA-approved indications1
See dosing information